* Agile Therapeutics Inc AGRX.OQ AGRX.O is expected
to show a
rise in quarterly revenue when it reports results on August 9.
* The Princeton New Jersey-based company is expected to
report a
91.7% increase in revenue to $4.076 million from $2.13 million a
year ago, according to the estimate from one analyst, based on
Refinitiv data.
* Refinitiv's mean analyst estimate for Agile Therapeutics
Inc is
for a loss of $7.00 per share.
* The one available analyst rating on the shares is
"hold".
* The mean earnings estimate of analysts was unchanged in
the last
three months.
This summary was machine generated August 7 at 18:31 GMT. All
figures in US dollars unless otherwise stated